Outpatient Service for Mid-trimester Termination of Pregnancy

Summary

This study seeks to evaluate the safety, acceptability and feasibility of an outpatient "day procedure" for medical abortion at 13-18 weeks gestation. The study regimen will consist of a single dose of 200 mg mifepristone to be taken orally either at home or at the hospital, followed approximately 24 - 48 hours later with administration of 400 mcg misoprostol. Repeat doses of 400 mcg (two tablets) of misoprostol will be administered buccally every three hours until the abortion is achieved.

Timeline

Start

2017-12-01

Primary completion

2018-12-31

Completion

2018-12-31

Drugs

Indications

No indication recorded.